Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Alysena 28

Starting date:
April 3, 2013
Posting date:
April 8, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I and II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-26663

Recalled Product

  1. Alysena 28

Reason

Packaged product may contain two rows of placebo tablets (14 tablets) and two rows of active contraceptive tablets (14 tablets) in the blister pack. Correct packaging is one row of placebo tablets (7 tablets) and three rows of active contraceptive tablets (21 tablets) in the blister pack.

As per the product monograph, in the case of a missed dose, use a non-hormonal method of contraception as an interim measure until you speak with your physician and obtain medical advice.

Depth of distribution

Wholesalers/distributors and retailers in BC, NB, NF, NS, ON, PE, QC

Affected products

A. Alysena 28

DIN, NPN, DIN-HIM
DIN 02387883
Dosage form
  • Tablets
Strength
  • 100 mcg levonorgestrel and 20 mcg ethinyl estradiol
Lot or serial number
  • LF01899A
Companies
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA

Advisory